Sponsor Pipeline

Immunocore Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
4
Recruiting
2
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 1/2
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05549297 Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma… Advanced Melanoma Recruiting
NCT06112314 IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma… Advanced Melanoma Recruiting
Phase 1/2
NCT06840119 Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers Cancer Recruiting
NCT04262466 Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint… Select Advanced Solid Tumors Active, Not Recruiting
Phase 1
NCT07156136 Study of IMC-P115C in Advanced PRAME-Positive Cancers PRAME Positive Recruiting
NCT07493122 Study of IMC-S118AI in Type 1 Diabetes Type 1 Diabetes Not Yet Recruiting
Disease Areas
Melanoma (2) Type 1 Diabetes (1) Diabetes (1)
Get alerts when Immunocore Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free